辅助生殖技术市场规模、份额及成长分析（按类型、最终用途和地区）－2025-2032 年产业预测

Assisted Reproductive Technology Market Size, Share, and Growth Analysis, By Type (In-Vitro Fertilization (IVF), Artificial Insemination), By End-Use (Fertility Clinics, Hospitals), By Region - Industry Forecast 2025-2032

出版日期: 2025年04月01日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

辅助生殖技术市场规模预计到 2023 年将达到 359.2 亿美元，从 2024 年的 389 亿美元成长到 2032 年的 736.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.3%。

由于不孕不育率上升以及人们对生育治疗和代孕的认识不断提高，全球辅助生殖技术 (ART) 市场正在经历显着增长。 ART 涵盖一系列方法，包括体外受精 (IVF) 和怀孕代孕，旨在帮助个人和夫妇怀孕。世界卫生组织 (WHO) 估计，2020 年将有约 4,800 万对夫妇和 1.86 亿个人面临不孕不育的诊断，这凸显了对此类服务的巨大需求。此外，美国疾病管制与预防中心强调，6% 至 12% 的美国多囊性卵巢症候群女性也患有不孕症，这进一步推动了需求。在公共和私营部门的资金支持以及技术的不断进步下，ART 市场的未来仍然强劲。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Merck KGaA（Germany）
Cook Medical（USA）
Vitrolife AB（Sweden）
CooperSurgical, Inc.（USA）
Irvine Scientific（USA）
Ferring Pharmaceuticals（Switzerland）
Genea Limited（Australia）
Cryolab Ltd.（UK）
Bloom IVF Center（India）
Cosmos Biomedical Ltd.（UK）
European Sperm Bank（Denmark）
Parallabs（UK）
Microm UK Ltd.（UK）
Esco Medical（Singapore）
IVFtech ApS（Denmark）
The Cooper Companies, Inc.（USA）
Thermo Fisher Scientific Inc.（USA）

结论和建议

简介目录

Product Code: SQMIG35G2228

Assisted Reproductive Technology Market size was valued at USD 35.92 billion in 2023 and is poised to grow from USD 38.9 billion in 2024 to USD 73.62 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The global market for Assisted Reproductive Technology (ART) is experiencing significant growth due to rising infertility rates and increased awareness of fertility treatments and surrogacy. ART encompasses a range of methods including in vitro fertilization (IVF) and gestational surrogacy, designed to assist individuals and couples in conceiving. The World Health Organization estimates that in 2020, approximately 48 million couples and 186 million individuals faced infertility diagnoses, emphasizing the scale of the need for these services. Additionally, the Centers for Disease Control and Prevention highlight that 6% to 12% of American women with PCOS also struggle with infertility, further propelling demand. With funding from both public and private sectors and ongoing technological advancements, the ART market's prospects remain robust.

Top-down and bottom-up approaches were used to estimate and validate the size of the Assisted Reproductive Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Assisted Reproductive Technology Market Segments Analysis

Global Assisted Reproductive Technology Market is segmented by Type, End-Use and region. Based on Type, the market is segmented into In-Vitro Fertilization (IVF), Artificial Insemination and Others. Based on End-Use, the market is segmented into Fertility Clinics, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Assisted Reproductive Technology Market

The rise in infertility rates, driven by factors like delayed childbirth, lifestyle modifications, and environmental influences, underscores the growing importance of Assisted Reproductive Technology (ART). As more couples seek solutions for their infertility issues, there is a corresponding increase in demand for ART services. This heightened interest not only highlights the need for viable reproductive options but also propels the growth of the ART industry, making it a vital component of modern reproductive health solutions. Consequently, the trend indicates a significant expansion potential for ART, reflecting society's evolving approach to family building in the face of fertility challenges.

Restraints in the Assisted Reproductive Technology Market

One of the primary challenges facing the Assisted Reproductive Technology (ART) market is the high cost associated with treatments such as in vitro fertilization (IVF) and other related procedures. These substantial expenses can limit accessibility and affordability for many patients, ultimately hindering the overall growth of the market, especially in areas that lack robust healthcare infrastructure. As a result, the financial burden can prevent individuals from seeking necessary ART services, thereby stifling market expansion in regions where the demand for such technologies exists but is unmet due to prohibitive costs.

Market Trends of the Assisted Reproductive Technology Market

The Assisted Reproductive Technology (ART) market is witnessing a significant trend towards the expansion of personalized solutions, bolstered by advancements in genetic screening and embryo analysis. This shift towards individualized ART therapies is driven by the desire to enhance overall success rates and optimize treatment efficiency. By addressing specific causes of infertility and tailoring approaches to meet individual patient needs, healthcare providers can offer more targeted and effective fertility treatments. As a result, this trend not only improves patient outcomes but also fosters continued innovation in the reproductive health sector, reflecting an evolving landscape that prioritizes personalized care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Advancement

Global Assisted Reproductive Technology Market Size by Type & CAGR (2025-2032)

Market Overview
In-Vitro Fertilization (IVF)
Artificial Insemination
Others

Global Assisted Reproductive Technology Market Size by End-Use & CAGR (2025-2032)

Market Overview
Fertility Clinics
Hospitals
Others

Global Assisted Reproductive Technology Market Size & CAGR (2025-2032)

North America (Type, End-Use)
- US
- Canada
Europe (Type, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolab Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bloom IVF Center (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cosmos Biomedical Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
European Sperm Bank (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parallabs (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microm UK Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Medical (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVFtech ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Cooper Companies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments